Biosimilar to Biosimilar Anti-VEGF Switching for Retinal Diseases

被引：4

作者：

Sharma, Ashish ^{[1
,6
]}

Loewenstein, Anat ^{[2
]}

Parachuri, Nikulaa ^{[3
]}

Kumar, Nilesh ^{[4
]}

Kuppermann, Baruch D. ^{[5
]}

机构：

[1] Lotus Eye Hosp & Inst, Coimbatore, TN, India

[2] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Div Ophthalmol, Tel Aviv, Israel

[3] Sankara Eye Hosp, Dept Vitreoretina, Coimbatore, TN, India

[4] Madhavi Netralaya, Ara, Bihar, India

[5] Univ Calif Irvine, Gavin Herbert Eye Inst, Dept Ophthalmol, Irvine, CA USA

[6] Lotus Eye Hosp & Inst, Avinashi Rd, Coimbatore 641014, TN, India

来源：

JOURNAL OF VITREORETINAL DISEASES | 2023年 / 7卷 / 06期

关键词：

biosimilar; switch; retina; anti-VEGF;

D O I：

10.1177/24741264231202080

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

[No abstract available]

引用

页码：474 / 476

页数：3

共 50 条

[41] Anti-VEGF therapy in the treatment of anterior segment neovascularization secondary to central retinal vein occlusion [J].

Kabesha, T. B. ;

Glacet-Bernard, A. ;

Rostaqui, O. ;

Souied, E. H. .

JOURNAL FRANCAIS D OPHTALMOLOGIE, 2015, 38 (05) :414-420

[42] The efficacy of dexamethasone implants following anti-VEGF failure for macular oedema in retinal vein occlusion [J].

Yap, Timothy E. ;

Husein, Salman ;

Miralles de Imperial-Ollero, Juan Antonio ;

Colizzi, Benedetta ;

Cordeiro, Maria Francesca ;

Younis, Saad .

EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2021, 31 (06) :3214-3222

[43] Laser photocoagulation, intravitreal anti-VEGF, and vitreous surgery for the treatment of juxtapapillary retinal capillary hemangioma [J].

Gunduz, Gamze Ucan ;

Gelisken, Oner ;

Yalcinbayir, Ozgur ;

Guler, Kazim .

INDIAN JOURNAL OF OPHTHALMOLOGY, 2019, 67 (12) :2104-2106

[44] Safety Profile of Anti-VEGF Agents on Retinal Pigment Epithelium Cells: In Vitro Cell Viability [J].

Bababeygy, Simon R. ;

Malik, Deepika ;

del Carpio, Javier Caceres ;

Boyer, David S. ;

Kenney, Cristina M. ;

Kuppermann, Baruch .

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)

[45] Retinal venous pressure is decreased after anti-VEGF therapy in patients with retinal vein occlusion–related macular edema [J].

Teruyo Kida ;

Josef Flammer ;

Katarzyna Konieczka ;

Tsunehiko Ikeda .

Graefe's Archive for Clinical and Experimental Ophthalmology, 2021, 259 :1853-1858

[46] Anti-VEGF Monotherapy vs Anti-VEGF and Steroid Combination Therapy for Diabetic Macular Edema: A Meta-analysis [J].

Grad, Justin ;

Hatamnejad, Amin ;

Dadak, Rohan ;

Sodhi, Simrat ;

Pattathil, Niveditha ;

Choudhry, Netan .

JOURNAL OF VITREORETINAL DISEASES, 2025, 9 (01) :70-83

[47] Switching anti-VEGF agent for wet AMD: evaluation of impact on visual acuity, treatment frequency and retinal morphology in a real-world clinical setting [J].

Elisabet Granstam ;

Sandra Aurell ;

Kersti Sjövall ;

Anna Paul .

Graefe's Archive for Clinical and Experimental Ophthalmology, 2021, 259 :2085-2093

[48] Switching anti-VEGF agent for wet AMD: evaluation of impact on visual acuity, treatment frequency and retinal morphology in a real-world clinical setting [J].

Granstam, Elisabet ;

Aurell, Sandra ;

Sjovall, Kersti ;

Paul, Anna .

GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2021, 259 (08) :2085-2093

[49] Switching maintenance infliximab therapy to biosimilar infliximab in inflammatory bowel disease patients [J].

Eberl, Anja ;

Huoponen, Saara ;

Pahikkala, Tapio ;

Blom, Marja ;

Arkkila, Perttu ;

Sipponen, Taina .

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2017, 52 (12) :1348-1353

[50] What to Expect When Switching to a Biosimilar: A US Healthcare Professional's Perspective [J].

Belton, Juanita ;

D'Apice, Nicholas .

CROHNS & COLITIS 360, 2024, 6 (04)

← 1 2 3 4 5 →